PPT-Abstract highlights EASL NAFLD Summit 2019

About these slides These slides provide highlights of new data presented at the EASL NAFLD Summit 2019 Please feel free to use adapt and share these slides for your own personal use however please acknowledge EASL as the source. 3. Rd. International . HIV/Hepatitis . Coinfection. . Meeting. Durban SA. Marina B. Klein, MD, MSc FRCP. (C). Chronic. Viral . Illness. Service. McGill University . Health. . Centre. How times have changed. Las Vegas, November 11-12, 2016. With Dr. Todd Singleton. Thank you!. For those of you that took time out of your busy schedule to come to our Annual Summit, we appreciate you!. Our Mission Statement. Finance Committee April 2019 1 February 2019 Financial Report AGENDA 2 February Highlights Forecast – FY 19 Forecast – 12 month rolling February 2019 Financial Report Volume Highlights 3 Inpatient activity continues to be strong. Outpatient under budget. New Advances for NAFLD/NASH NAFLD: A Spectrum of Disease Who Is at Risk for NAFLD and NASH? Prevalence of NAFLD in Europe Prevalence of NAFLD and NASH Predicted to Increase in Europe What Is the Burden of NAFLD in Europe? highlights from the. EUROPEAN . society . of medical oncology . (. ESMO. ) . congress . 2019. in . B. arcelona. Legal Disclaimer. This slide-kit is intended for healthcare professionals only. The authors of this report were supported by TESARO Bio Germany GmbH, their participation at the ESMO 2019 was in agreement with legal and ethical guidelines. Moderator. Kris V. Kowdley, MD . Director . Liver Institute Northwest . Clinical Professor. Elson S. Floyd College of Medicine. Washington State University. Seattle, Washington . Overview of Discussion. Hepatologist. East & North Hertfordshire NHS Trust. Royal Free London NHS Foundation Trust. ELF Research Group. University College London. Liver disease. Scale of the problem. Liver disease is the 5. William Alazawi MA(. Cantab. ) PhD MRCP. Senior Lecturer and Consultant in . Hepatology. Queen Mary, University of London. Does Liver Disease Matter?. Mortality in England & Wales. Liver-related mortality in under 65s. Mohammad . Hassabi. (MD). Assistant Professor of Sports and Exercise Med. Dept.. Shahid. . Beheshti. University of Medical Sciences. Taleghani. Medical Center. Physical activity. Exercise. . Sports. not an equal opportunity: implications for women’s health. Alina M. Allen MD. , Patrick S. Kamath MD, Joseph J. Larson, . Kymberly D. Watt MD, . Sharonne. N. Hayes MD, Terry M. . Therneau. PhD. Mayo Clinic, Rochester, MN. April 10. –14. , 2019. Vienna, Austria. Disclaimer. These non-promotional slides are intended to be used as educational material only in response to an unsolicited question or request. The double-dagger (. Research Institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences. 21 July 2016. Nonalcoholic Fatty Liver Disease . Case Discussion . 2. Case 1. Case 1. A generally healthy 42 y/o lady came to you for evaluation of fatty liver (grade I) discovered during a routine abdominal ultrasound.. Diabetes. Hypertension. HDL < 1 . mmol. /L . Triglycerides > 1.7 . mmol. /L. Suspicion of NAFLD ?. Remember normal LFT’s do not rule out liver disease Exclude significant alcohol misuse (intermediate or high risk group in the alcohol related liver disease pathway) before diagnosing NAFLD via this pathway. Carolyn Yanavich, . Antônio Pacheco, Sandra . W Cardoso, Estevão Portela, Ursula . B Chaves, Ricardo Santos, . Michelle Morata, . Valdilea . G Veloso, Beatriz . Grinsztejn, . Hugo Perazzo. National Institute of .